Docking of oxalyl aryl amino benzoic acid derivatives into PTP1B

Neelam Verma1, Minakshi Mittal, Raman Kumar Verma

  • 1Department of Biotechnology, Punjabi University, Patiala. neelam_verma2@rediffmail.com

Bioinformation
|February 25, 2009
PubMed

Insights

Novel oxalyl aryl amino benzoic acid derivatives show promise as selective inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B). These compounds enhance insulin sensitivity and could be valuable in treating type-II diabetes and metabolic syndrome.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Protein Tyrosine Phosphatases (PTPs) are key regulators of insulin signaling.
  • PTP1B is a validated therapeutic target for enhancing insulin action in insulin resistance, obesity, and type-II diabetes.
  • Inhibiting PTP1B improves insulin sensitivity and glucose metabolism.

Purpose of the Study:

  • To design and evaluate novel oxalyl aryl amino benzoic acid derivatives as selective PTP1B inhibitors.
  • To investigate the molecular interactions responsible for PTP1B inhibition and selectivity.
  • To identify potential insulin sensitizers for metabolic diseases.

Main Methods:

  • Molecular docking of modified oxalyl aryl amino benzoic acid derivatives into the PTP1B structure using BioMed CAChe 6.1.
  • Assessment of selectivity against other phosphatases (SHP-2, LAR, CD45, TCPTP).
  • Analysis of key amino acid residues (Gly220, Arg221) and hydrophobic interactions (Meth258, Phe52) for specificity.

Main Results:

  • The modified oxalyl aryl amino benzoic acid derivatives demonstrated good selectivity for PTP1B.
  • Hydrogen bonding interactions with Gly220 and Arg221 were identified as crucial for specificity.
  • Derivative [1b (a2, b2, c1, d)] exhibited a significantly better docking score (-131.740 Kcal/mol) compared to the active ligand (-98.584 Kcal/mol).
  • Hydrophobic interactions of the derivative's methionine side chain with PTP1B residues Meth258 and Phe52 were observed.

Conclusions:

  • Oxalyl aryl amino benzoic acid derivatives are effective PTP1B inhibitors with high selectivity.
  • The identified interactions provide a basis for designing more potent and specific PTP1B inhibitors.
  • These compounds hold potential as therapeutic agents for type-II diabetes and metabolic syndrome.

Related Concept Videos

Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Lipids as Anchors01:32

Lipids as Anchors

In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...